205 related articles for article (PubMed ID: 23715578)
1. Histologic transformation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Lee E; Kim TM; Lim Y; Jeon YK; Go H; Kim CW; Heo DS
J Clin Oncol; 2013 Jul; 31(19):e332-4. PubMed ID: 23715578
[No Abstract] [Full Text] [Related]
2. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.
Beltran BE; Castillo JJ; Salas R; Quiñones P; Morales D; Cotrina E; Miranda RN; Sotomayor EM
Leuk Lymphoma; 2011 Jan; 52(1):153-6. PubMed ID: 21219127
[No Abstract] [Full Text] [Related]
3. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
Yang QX; Pei XJ; Tian XY; Li Y; Li Z
Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
[TBL] [Abstract][Full Text] [Related]
4. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
5. Leukocytoclastic vasculitis as early manifestation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Zoroquiain P; González S; Molgó M; Rodríguez A; Valbuena JR
Am J Dermatopathol; 2012 May; 34(3):330-4. PubMed ID: 22197862
[TBL] [Abstract][Full Text] [Related]
6. Hope for very elderly patients with diffuse large B-cell lymphoma.
Ribera JM
Lancet Oncol; 2011 May; 12(5):412-3. PubMed ID: 21482185
[No Abstract] [Full Text] [Related]
7. Multiple cytokine-producing aggressive EBV-positive diffuse large B cell lymphoma, not otherwise specified with hemophagocytic syndrome.
Nakayama S; Morita Y; Espinoza JL; Rai S; Taniguchi Y; Taniguchi T; Miyake Y; Tanaka H; Ashida T; Matsumura I
Ann Hematol; 2020 Feb; 99(2):381-383. PubMed ID: 31768673
[No Abstract] [Full Text] [Related]
8. Bilateral psoas muscle lymphoma: an unusual presentation of EBV-positive diffuse large B-cell lymphoma of the elderly.
Ikebe T; Sasaki H; Saburi Y; Ogata M
Int J Hematol; 2015 Nov; 102(5):509-10. PubMed ID: 26440976
[No Abstract] [Full Text] [Related]
9. A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen?
Tadmor T; McLaughlin P; Polliack A
Leuk Lymphoma; 2010 May; 51(5):737-8. PubMed ID: 20367567
[No Abstract] [Full Text] [Related]
10. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
12. Hidden superpower.
McGuirt J
JAAPA; 2019 May; 32(5):66. PubMed ID: 31033720
[No Abstract] [Full Text] [Related]
13. Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma.
Poon F; Ieremia E; Collins G; Matin RN
Am J Dermatopathol; 2019 Dec; 41(12):927-930. PubMed ID: 31599749
[TBL] [Abstract][Full Text] [Related]
14. The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.
Hardak E; Oren I; Dann EJ; Yigla M; Faibish T; Rowe JM; Avivi I
Acta Haematol; 2012; 127(2):110-4. PubMed ID: 22178955
[TBL] [Abstract][Full Text] [Related]
15. Neutropenic fever following chemotherapy in a patient with lymphoma.
Book L
Oncol Nurs Forum; 2008 Nov; 35(6):885-7. PubMed ID: 18980919
[No Abstract] [Full Text] [Related]
16. Metabolic tumour volume and response to therapy in diffuse large B-cell lymphoma.
Campiotti L; Suter MB; De Palma D; Proserpio I; Uccella S; Squizzato A
Hematol Oncol; 2019 Aug; 37(3):308-309. PubMed ID: 30933368
[No Abstract] [Full Text] [Related]
17. Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma.
Lee T; Park BG; You E; Cho YU; Jang S; Lee SM; Suh C; Park CJ
Ann Lab Med; 2018 Mar; 38(2):172-175. PubMed ID: 29214764
[No Abstract] [Full Text] [Related]
18. Synchronous Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly and Epstein-Barr virus-positive classical Hodgkin lymphoma.
Hwang YY; Leung AY; Lau WH; Loong F; So JC; Tse E; Kwong YL
Histopathology; 2011 Aug; 59(2):352-5. PubMed ID: 21884219
[No Abstract] [Full Text] [Related]
19. Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma.
Palmowski M; Zechmann C; Satzl S; Bartling S; Hallscheidt P
Ann Hematol; 2008 Apr; 87(4):337-8. PubMed ID: 17929016
[No Abstract] [Full Text] [Related]
20. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Peyrade F; Jardin F; Thieblemont C; Thyss A; Emile JF; Castaigne S; Coiffier B; Haioun C; Bologna S; Fitoussi O; Lepeu G; Fruchart C; Bordessoule D; Blanc M; Delarue R; Janvier M; Salles B; André M; Fournier M; Gaulard P; Tilly H;
Lancet Oncol; 2011 May; 12(5):460-8. PubMed ID: 21482186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]